Intravenous administration of a decoy oligonucleotide against SP1 (R-SP1 decoy ODN), effectively suppressed hepatic fibrosis in these mice by inhibition of TGF-β signaling, and suppression of inflammatory cell accumulation and macrophage activation [159]. This evidence concerns the gene TGFB1 and Hepatic fibrosis.